RBR-8969zg
Not yet recruiting
未知
Clinical Trial using N-acetylcysteine for treatment of 2019-nCoV Pneumonia
niversidade de São Paulo0 sitesApril 13, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Severe acute respiratory syndrome
- Sponsor
- niversidade de São Paulo
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Volunteers; Both genders; Admitted to the Emergency Department with diagnosis of Acute Respiratory Syndrome, presumed or confirmed; Age equal to or greater than 18 years; Informed consent form (ICF) signed by the patient or legal guardian.
Exclusion Criteria
- •Patients with known allergy to N acetylcysteine; Pregnant women; In need of immediate mechanical ventilation or Refusal or inability to obtain consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease.Chronic obstructive pulmonary diseaseRespiratoryPulmonary diseaseISRCTN21676344Health Research Council of New Zealand50
Recruiting
Phase 2
The Post Anaesthesia N-Acetycysteine Cognitive Evaluation trial, investigating the potential for N-Acetylcysteine to reduce cognitive dysfunction following major elective non-cardiac surgeryPost Operative Cognitive DysfunctionSurgical Stress ResponsePost Operative Mood DisorderPost surgical painAnaesthesiology - AnaestheticsMental Health - Studies of normal psychology, cognitive function and behaviourSurgery - Other surgeryACTRN12614000411640The Geelong Hospital370
Not yet recruiting
Phase 3
AC-PTLD TrialTuberculosisPACTR202407655325739The Aurum Institute484
Completed
Phase 2
Adjuvant N Acetylcysteine for Post Traumatuic Stress DisorderACTRN12618001784202Austin Health105
Active, not recruiting
Not Applicable
A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardiac catheterisation for percutaneous coronary interventions - the CON NEC T” trial - CONNECTEUCTR2009-011175-70-GBiverpool Heart and Chest Hospital